These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Connecting type 1 and type 2 diabetes through innate immunity. Odegaard JI; Chawla A Cold Spring Harb Perspect Med; 2012 Mar; 2(3):a007724. PubMed ID: 22393536 [TBL] [Abstract][Full Text] [Related]
7. [Cells of innate and adaptive immunity in type 2 diabetes and obesity]. Guzmán-Flores JM; López-Briones S Gac Med Mex; 2012; 148(4):381-9. PubMed ID: 22976756 [TBL] [Abstract][Full Text] [Related]
8. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757 [TBL] [Abstract][Full Text] [Related]
9. Innate lymphoid cell subsets and their cytokines in autoimmune diseases. Maleki A; Khanmiri JM; Eshrat Abadi MK; Soveyzi F; Moazzami B; Hamblin MR; Rezaei N Eur Cytokine Netw; 2020 Dec; 31(4):118-128. PubMed ID: 33648919 [TBL] [Abstract][Full Text] [Related]
10. Low proliferative potential of adipose-derived stromal cells associates with hypertrophy and inflammation in subcutaneous and omental adipose tissue of patients with type 2 diabetes mellitus. Stafeev I; Podkuychenko N; Michurina S; Sklyanik I; Panevina A; Shestakova E; Yah'yaev K; Fedenko V; Ratner E; Vorotnikov A; Menshikov M; Yashkov Y; Parfyonova Y; Shestakova M J Diabetes Complications; 2019 Feb; 33(2):148-159. PubMed ID: 30482492 [TBL] [Abstract][Full Text] [Related]
12. Autoimmune responses and inflammation in type 2 diabetes. Prasad M; Chen EW; Toh SA; Gascoigne NRJ J Leukoc Biol; 2020 May; 107(5):739-748. PubMed ID: 32202348 [TBL] [Abstract][Full Text] [Related]
13. The role of inflammatory cytokines in diabetes and its complications. King GL J Periodontol; 2008 Aug; 79(8 Suppl):1527-34. PubMed ID: 18673007 [TBL] [Abstract][Full Text] [Related]
14. Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities. SantaCruz-Calvo S; Bharath L; Pugh G; SantaCruz-Calvo L; Lenin RR; Lutshumba J; Liu R; Bachstetter AD; Zhu B; Nikolajczyk BS Nat Rev Endocrinol; 2022 Jan; 18(1):23-42. PubMed ID: 34703027 [TBL] [Abstract][Full Text] [Related]
15. G Protein-Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus. Riddy DM; Delerive P; Summers RJ; Sexton PM; Langmead CJ Pharmacol Rev; 2018 Jan; 70(1):39-67. PubMed ID: 29233848 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of insulin resistance in diabetes. Soumaya K Adv Exp Med Biol; 2012; 771():240-51. PubMed ID: 23393683 [TBL] [Abstract][Full Text] [Related]
17. Altered foetoplacental vascular endothelial signalling to insulin in diabesity. Pardo F; Subiabre M; Fuentes G; Toledo F; Silva L; Villalobos-Labra R; Sobrevia L Mol Aspects Med; 2019 Apr; 66():40-48. PubMed ID: 30849412 [TBL] [Abstract][Full Text] [Related]
18. Innate immunity as the trigger of systemic autoimmune diseases. Saferding V; Blüml S J Autoimmun; 2020 Jun; 110():102382. PubMed ID: 31883831 [TBL] [Abstract][Full Text] [Related]
19. MECHANISMS IN ENDOCRINOLOGY: Metabolic and inflammatory pathways on the pathogenesis of type 2 diabetes. Coope A; Torsoni AS; Velloso LA Eur J Endocrinol; 2016 May; 174(5):R175-87. PubMed ID: 26646937 [TBL] [Abstract][Full Text] [Related]
20. Ceramides in insulin resistance and lipotoxicity. Summers SA Prog Lipid Res; 2006 Jan; 45(1):42-72. PubMed ID: 16445986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]